Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tobias Dreyer

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Cancer Metastasis Reviews|September 5, 2019
Proteolytic chemokine cleavage as a regulator of lymphocytic infiltration in solid tumorsHolger Bronger, Viktor Magdolen, Peter Goettig, et al.
International Journal of Molecular Sciences|January 10, 2026
Drug Discovery Strategies for Kallikrein-Related PeptidasesTobias Dreyer, Daniela Schuster, Viktor Magdolen, et al.
Expert Review of Molecular Diagnostics|May 5, 2021
The prognostic and diagnostic potential of kallikrein-related peptidases in ovarian cancerMaximilian Riedel, Holger Bronger, Viktor Magdolen, et al.
American Journal of Cancer Research|October 17, 2018
Elevated tumor tissue protein expression levels of kallikrein-related peptidases KLK10 and KLK11 are associated with a better prognosis in advanced high-grade serous ovarian cancer patientsXiaocong Geng, Yueyang Liu, Tobias Dreyer, et al.
Clinical Biochemistry|December 12, 2022
Repression of miR-146a in predicting poor treatment outcome in triple-negative breast cancerKonstantina Panoutsopoulou, Yueyang Liu, Margaritis Avgeris, et al.
Oncology Letters|June 11, 2017
Induction of cathepsin B by the CXCR3 chemokines CXCL9 and CXCL10 in human breast cancer cellsHolger Bronger, Anne Karge, Tobias Dreyer, et al.
Pathophysiology : the Official Journal of the International Society for Pathophysiology|April 24, 2026
High uPAR and Low miR-221 Expression Predict Poor Disease-Free Survival in Triple-Negative Breast CancerWeiwei Gong, Yueyang Liu, Natalie Falkenberg, et al.
FEBS Open Bio|December 3, 2025
KLK7 overexpression promotes an aggressive phenotype and facilitates peritoneal dissemination in colorectal cancer cellsYosr Z Haffani, Tobias Dreyer, Meriem Naim, et al.
Journal of Ovarian Research|October 22, 2020
Prognostic value of kallikrein-related peptidase 7 (KLK7) mRNA expression in advanced high-grade serous ovarian cancerWeiwei Gong, Yueyang Liu, Eleftherios P Diamandis, et al.
Plos One|February 28, 2019
Characterization of kallikrein-related peptidase 4 (KLK4) mRNA expression in tumor tissue of advanced high-grade serous ovarian cancer patientsWeiwei Gong, Yueyang Liu, Christof Seidl, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Cancer Metastasis Reviews|September 5, 2019
Proteolytic chemokine cleavage as a regulator of lymphocytic infiltration in solid tumorsHolger Bronger, Viktor Magdolen, Peter Goettig, et al.
International Journal of Molecular Sciences|January 10, 2026
Drug Discovery Strategies for Kallikrein-Related PeptidasesTobias Dreyer, Daniela Schuster, Viktor Magdolen, et al.
Expert Review of Molecular Diagnostics|May 5, 2021
The prognostic and diagnostic potential of kallikrein-related peptidases in ovarian cancerMaximilian Riedel, Holger Bronger, Viktor Magdolen, et al.
American Journal of Cancer Research|October 17, 2018
Elevated tumor tissue protein expression levels of kallikrein-related peptidases KLK10 and KLK11 are associated with a better prognosis in advanced high-grade serous ovarian cancer patientsXiaocong Geng, Yueyang Liu, Tobias Dreyer, et al.
Clinical Biochemistry|December 12, 2022
Repression of miR-146a in predicting poor treatment outcome in triple-negative breast cancerKonstantina Panoutsopoulou, Yueyang Liu, Margaritis Avgeris, et al.
Oncology Letters|June 11, 2017
Induction of cathepsin B by the CXCR3 chemokines CXCL9 and CXCL10 in human breast cancer cellsHolger Bronger, Anne Karge, Tobias Dreyer, et al.
Pathophysiology : the Official Journal of the International Society for Pathophysiology|April 24, 2026
High uPAR and Low miR-221 Expression Predict Poor Disease-Free Survival in Triple-Negative Breast CancerWeiwei Gong, Yueyang Liu, Natalie Falkenberg, et al.
FEBS Open Bio|December 3, 2025
KLK7 overexpression promotes an aggressive phenotype and facilitates peritoneal dissemination in colorectal cancer cellsYosr Z Haffani, Tobias Dreyer, Meriem Naim, et al.
Journal of Ovarian Research|October 22, 2020
Prognostic value of kallikrein-related peptidase 7 (KLK7) mRNA expression in advanced high-grade serous ovarian cancerWeiwei Gong, Yueyang Liu, Eleftherios P Diamandis, et al.
Plos One|February 28, 2019
Characterization of kallikrein-related peptidase 4 (KLK4) mRNA expression in tumor tissue of advanced high-grade serous ovarian cancer patientsWeiwei Gong, Yueyang Liu, Christof Seidl, et al.
Pageof 3